These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom. Gross DJ; Ratner J; Perez J; Glavin SL Health Care Financ Rev; 1994; 15(3):127-40. PubMed ID: 10137794 [TBL] [Abstract][Full Text] [Related]
12. The UK pharmaceutical market. An overview. Towse A Pharmacoeconomics; 1996; 10 Suppl 2():14-25. PubMed ID: 10163432 [TBL] [Abstract][Full Text] [Related]
13. New NICE criteria for drug access. Fricker J Lancet Oncol; 2017 May; 18(5):576. PubMed ID: 28343973 [No Abstract] [Full Text] [Related]
14. The market for pharmaceuticals. Bergenheim K; Braun U Dev Health Econ Public Policy; 1998; 7():187-208. PubMed ID: 10538829 [No Abstract] [Full Text] [Related]
15. Regulating the pharmaceutical industry. Regulation may no longer be necessary. Rowlatt P BMJ; 1998 Jan; 316(7126):227; author reply 228. PubMed ID: 9468702 [No Abstract] [Full Text] [Related]
16. Changes to the regulation of drug prices in the UK. Collier J BMJ; 2008 Dec; 337():a2735. PubMed ID: 19114449 [No Abstract] [Full Text] [Related]
17. NHS spending on drugs is frozen for two years under price deal. Wise J BMJ; 2013 Nov; 347():f6731. PubMed ID: 24201064 [No Abstract] [Full Text] [Related]
18. Pfizer to make palbociclib temporarily free on NHS. Burki TK Lancet Oncol; 2017 Jun; 18(6):e309. PubMed ID: 28506556 [No Abstract] [Full Text] [Related]
19. Nine drug company chiefs are charged with conspiracy to defraud NHS. Dyer O BMJ; 2006 Apr; 332(7546):872. PubMed ID: 16613948 [No Abstract] [Full Text] [Related]
20. Regulating the price of the UK's drugs: second thoughts after the government's first report. Earl-Slater A BMJ; 1997 Feb; 314(7077):365-8. PubMed ID: 9040338 [No Abstract] [Full Text] [Related] [Next] [New Search]